ClinicalTrials.gg
RecruitingNCT06674473Updated Sep 15, 2026

Evaluation of Long-term Isokinetic Training of Knee Joint

An interventional study of With robot assistance and traditional rehabilitation in Knee Injuries and Disorders, sponsored by Peking University Third Hospital. Recruiting at 1 site in China. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Peking University Third Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

The goal of this clinical trial is to assess the effectiveness of isokinetic rehabilitation training under optimal stiffness in patients undergoing knee joint rehabilitation. The main questions it aims to answer are:

  • Does isokinetic training under optimal stiffness lead to greater force exertion compared to traditional bodyweight training?
  • What are the long-term (6-week) effects of isokinetic training under optimal stiffness on joint flexibility and muscle strength? Researchers will compare the effects of isokinetic training under optimal stiffness to traditional bodyweight training to see if isokinetic training produces superior improvements in muscle strength, flexibility, and overall functional recovery.

Participants will:

  • Perform regular training sessions using a portable knee joint isokinetic trainer, customized to their optimal stiffness for maximum force exertion.
  • Engage in a 6-week rehabilitation program, with assessments at the beginning, and end of the study to evaluate changes in muscle strength, and functional recovery.
02

Conditions studied

  • Knee Injuries and Disorders
03

In context

Knee Injuries

267 studies on the registry are indexed under Knee Injuries; 59 are open to participants now.

This study's planned enrollment of 12 is below the median of 49 across 178 interventional studies indexed under Knee Injuries.

Browse Knee Injuries studies →

Lead sponsor

Peking University Third Hospital is the lead sponsor of 752 studies on the registry; 273 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age between 20-60 years.
  2. Patients with unilateral anterior cruciate ligament (ACL) rupture (with or without meniscus injury), posterior cruciate ligament (PCL) rupture, meniscal tear (M), and patellar dislocation (PD).

4. Postoperative period of 3-6 months. 5. No restriction in knee extension or flexion movements.

Exclusion criteria

Exclusion Criteria:

  1. Patients with major diseases or conditions such as coronary heart disease, myocardial infarction, heart failure, cerebral infarction, cerebral hemorrhage, or malignant tumors.
  2. Pregnant or breastfeeding women and other special populations.
  3. Patients who refuse to sign the form or are unable to complete the entire study process.
  4. Patients currently infected with (HIV), or with a history of infectious or C.
  5. Patients with concurrent medical issues, including but not limited to: (1) Uncontrolled hypertension (systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥95 mmHg), congestive heart failure ( functional classification of stage III or IV). (2) Patients with mental incapacity or an inability to comprehend the study requirements.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Hepatitis B tests

Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.

Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Robot-assisted Rehabilitation

    In this clinical trial, 6 patients who meet the inclusion criteria will be enrolled in the experimental group to undergo rehabilitation using a portable isokinetic device.

    Device: With robot assistance

  • Active comparator
    None-robot-assisted Rehabilitation

    The control group will consist of 6 patients who meet the inclusion criteria and will undergo traditional isotonic and isometric rehabilitation

    Behavioral: traditional rehabilitation

Interventions

  • DeviceWith robot assistance

    Use a portable isokinetic device

  • Behavioraltraditional rehabilitation

    Use traditional isotonic and isometric rehabilitation

06

What researchers measure

Primary outcomes

  1. Cross-sectional area of the quadriceps

    Using MRI,Up to 6 weeks

    Time frame: Before 1st practice, and after 12th practice (6 weeks * 2 practices/week = 12 practices)

  2. Cross-sectional area of the hamstrings

    using MRI, Up to 6 weeks

    Time frame: Before 1st practice, and after 12th practice (6 weeks * 2 practices/week = 12 practices)

  3. Peak flexion and extension knee torque

    Using an integrated torque sensor

    Time frame: During each practice (6 weeks * 2 practices/week = 12 practices).

  4. Average flexion and extension knee torque

    Time frame: During each practice (6 weeks * 2 practices/week = 12 practices).

  5. Flexion and extension knee work

    Work=Torque\*Speed

    Time frame: In each ptractice (6 weeks * 2 practices /week = 12 practices).

Secondary outcomes

  1. Thigh circumference

    10 cm proximal to the superior pole of the patella

    Time frame: In each ptractice (6 weeks * 2 practices /week = 12 practices).

  2. Knee joint pain score (VAS score)

    Up to 6 weeks,max. =100, min. =0, Visual Analogue Scale=VSA, A higher score indicates greater pain intensity.

    Time frame: Before 1st practice, and after 12th practice (6 weeks * 2 practices/week = 12 practices)

  3. Surface electromyography signals of quadricep and hamstrings

    SEMG signals are used to evaluate the instant effect brought by the optimal stiffness.

    Time frame: During optimal stiffness measurements

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06674473
Collaborators
Beihang University
Responsible party
Yuan Fuzhen (Principle Investigator, Peking University Third Hospital) — Principal investigator
First posted
Nov 5, 2024
Start date
Nov 6, 2024
Primary completion
Oct 20, 2026 (estimated)
Completion
Oct 20, 2026 (estimated)
Last update
Sep 15, 2026

Study contacts

Yuanzhen Yuan, Dr.
Contact
yanggangfeng@buaa.edu.cn
+8618811728786

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion